Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.614, 2010-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Risperidone for schizophrenia worth its cost?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 317, 2001-01 ,pp. :
Access to resources
Recommend
DTC communication key to improving patient compliance?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 436, 2003-01 ,pp. :
Drug expenditure the key to cost containment?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 318, 2001-01 ,pp. :
Cost effectiveness of adjuvant chemotherapy a generation game?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 634, 2011-01 ,pp. :
Do physicians consider cost effectiveness in clinical practice?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 301, 2001-01 ,pp. :